W 274 (Lamotrigine Extended-Release 50 mg)
Pill with imprint W 274 is Pink, Round and has been identified as Lamotrigine extended-release 50 mg. It is supplied by Wockhardt USA LLC.
Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; borderline personality disorder; anxiety; seizure prevention (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for W 274
Lamotrigine extended-release
- Imprint:
- W 274
- Strength:
- 50 mg
- Color:
- Pink
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Triazine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Wockhardt USA LLC
- Inactive Ingredients:
- diethyl phthalate
ferric oxide red
hypromelloses
lactose monohydrate
magnesium stearate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polyethylene glycol
magnesium silicate
titanium dioxide
Note: Inactive ingredients may vary.
More about lamotrigine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 876 Reviews – Add your own review/rating
- Drug class: triazine anticonvulsants
Consumer resources
- Lamotrigine
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Orally Disintegrating Tablets
- Lamotrigine Tablets
- Lamotrigine Extended-Release Tablets
- Lamotrigine (Advanced Reading)
Other brands: Lamictal, Lamictal XR, Lamictal ODT, Lamictal CD
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
